All HCCI Reports
HCCI’s original reports powered by #HCCIdata

USA Today: Walmart launching its own low-cost insulin to 'revolutionize' affordability for diabetics

HCCI's research on insulin prices was featured in USA Today.

From the article: "The lower-cost insulin is being released by Walmart in response to surging costs for the treatment used for patients with diabetes. According to the Health Care Cost Institute, a non-profit organization which sheds light on health care spending, the average price for an insulin prescription nearly doubled from 2012 ($344) to 2016 ($666)."


Walmart launching its own low-cost insulin for diabetes patients

Walmart will launch its own brand of insulin, which the retailing giant says will "revolutionize the access and affordability" of diabetes treatments.
Stay Informed

When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.